company background image
ONVO

Organovo Holdings NasdaqCM:ONVO Stock Report

Last Price

US$2.03

Market Cap

US$17.7m

7D

-9.0%

1Y

-71.5%

Updated

26 Sep, 2022

Data

Company Financials
ONVO fundamental analysis
Snowflake Score
Valuation2/6
Future Growth0/6
Past Performance0/6
Financial Health6/6
Dividends0/6

ONVO Stock Overview

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease.

Organovo Holdings, Inc. Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Organovo Holdings
Historical stock prices
Current Share PriceUS$2.03
52 Week HighUS$7.24
52 Week LowUS$1.71
Beta1.14
1 Month Change-21.01%
3 Month Change18.71%
1 Year Change-71.53%
3 Year Change-61.04%
5 Year Change-95.43%
Change since IPO-93.85%

Recent News & Updates

Aug 24
Here's Why We're Not Too Worried About Organovo Holdings' (NASDAQ:ONVO) Cash Burn Situation

Here's Why We're Not Too Worried About Organovo Holdings' (NASDAQ:ONVO) Cash Burn Situation

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

May 10
We're Hopeful That Organovo Holdings (NASDAQ:ONVO) Will Use Its Cash Wisely

We're Hopeful That Organovo Holdings (NASDAQ:ONVO) Will Use Its Cash Wisely

Just because a business does not make any money, does not mean that the stock will go down. For example, although...

Shareholder Returns

ONVOUS BiotechsUS Market
7D-9.0%-5.3%-6.9%
1Y-71.5%-30.6%-23.7%

Return vs Industry: ONVO underperformed the US Biotechs industry which returned -30% over the past year.

Return vs Market: ONVO underperformed the US Market which returned -23% over the past year.

Price Volatility

Is ONVO's price volatile compared to industry and market?
ONVO volatility
ONVO Average Weekly Movement15.2%
Biotechs Industry Average Movement11.1%
Market Average Movement6.9%
10% most volatile stocks in US Market15.7%
10% least volatile stocks in US Market2.8%

Stable Share Price: ONVO is more volatile than 75% of US stocks over the past 3 months, typically moving +/- 15% a week.

Volatility Over Time: ONVO's weekly volatility (15%) has been stable over the past year, but is still higher than 75% of US stocks.

About the Company

FoundedEmployeesCEOWebsite
200714Keith Murphyhttps://www.organovo.com

Organovo Holdings, Inc., a biotechnology company, focuses on developing 3D tissues that recapitulate key aspects of human disease. Its 3D human tissue platform includes its proprietary NovoGen Bioprinters, which are automated devices that enable the fabrication of 3D living tissues comprised mammalian cells; and related technologies for preparing bio-inks and bioprinting multicellular tissues with complex architecture. The company offers ExVive human liver tissue and ExVive human kidney tissue used for predictive preclinical testing of drug compounds.

Organovo Holdings, Inc. Fundamentals Summary

How do Organovo Holdings's earnings and revenue compare to its market cap?
ONVO fundamental statistics
Market CapUS$17.69m
Earnings (TTM)-US$12.13m
Revenue (TTM)US$1.50m

11.8x

P/S Ratio

-1.5x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report
ONVO income statement (TTM)
RevenueUS$1.50m
Cost of RevenueUS$3.76m
Gross Profit-US$2.26m
Other ExpensesUS$9.87m
Earnings-US$12.13m

Last Reported Earnings

Jun 30, 2022

Next Earnings Date

n/a

Earnings per share (EPS)-1.39
Gross Margin-150.67%
Net Profit Margin-808.73%
Debt/Equity Ratio0%

How did ONVO perform over the long term?

See historical performance and comparison